1-3 of 3
Jaume Villalta, MD
Close
Sort by
Journal Articles

Reversal of the Antithrombotic Action of Rivaroxaban and Dabigatran: A Clinical Study in Healthy Volunteers.

Ana M Galan, Ph.D., Eduardo Arellano-Rodrigo, MD, PhD, Victoria Veronica Sanz, Patricia Molina, Joan Carles Reverter, MD, PhD, Xavier CarneĢ, MD, PhD, Jaume Villalta, MD, PhD, Dolors Tassies, MD, PhD, Maribel Diaz-Ricart, PhD., Gines Escolar, MD. PhD
Journal: Blood
Blood (2012) 120 (21): 2261.
https://doi.org/10.1182/blood.V120.21.2261.2261
Published: 2012
Journal Articles

Coagulation Factor Concentrates Restore Alterations in Hemostasis Induced by a High Dose of Apixaban: Studies in Vitro with Circulating Human Blood.

Gines Escolar, MD. PhD, Eduardo Arellano-Rodrigo, MD, PhD, Joan Carles Reverter, MD, PhD, Jaume Villalta, MD, PhD, Victoria Veronica Sanz, Patricia Molina, Maribel Diaz-Ricart, PhD., Ana M Galan, PhD.
Journal: Blood
Blood (2012) 120 (21): 2263.
https://doi.org/10.1182/blood.V120.21.2263.2263
Published: 2012
Journal Articles

A Cost-Benefit Analysis of D-Dimer Measurement by a High Sensitivity Asay, as the First Step to Rule out a Venous Thromboembolism Suspected Episode, Independently of Pretest Clinical Probability.

Francesc J Casals, MD, PhD, Davide Bernaudo, MD, Jaume Villalta, MD, Naila Lozano, RN, Gines Escolar, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1280.
https://doi.org/10.1182/blood.V112.11.1280.1280
Published: 2008